首次出版:最新修訂:March 2009交付方式:特快專遞(2-3天送達)
定購電話:0755-82571522、82571566、400-008-1522
24小時服務熱線:138 0270 8576 定制報告
版本 | 在線版 | 電子版+印刷版 | 在線報告庫(超1000份報告)全庫 |
---|---|---|---|
優(yōu)惠價 | RMB 6800 | RMB 7800 | RMB 9800 |
原價 | RMB 9600 | RMB 9800 | - |
聯系電話: 400 008 0586; 0755-82571568
微信掃碼:
1.EXECUTIVESUMMARY
·ExecutiveSummary
Introduction
2.TOTALMARKET
·ResearchScopeandMethodology
ScopeandSegmentation
ResearchMethodology
·DiseaseOverview
Introduction
DiseaseDefinition
Symptoms
RiskFactors
Diagnosis
Treatments
DrugDeliveryMethods
DiseaseStatistics
CompetitiveStructure
·PatientOutlook
PatientForecasts
·GeneralMarketTrends
Challenges
StrategicRecommendationsforChallenges
MarketDrivers
MarketRestraints
3.MARKETEDTHERAPIESOVERVIEW
·Overview
Bronchodilators
Anti-inflammatories
CombinationTherapies
NovelTherapeuticApproaches
4.APPENDIX
·DecisionSupportDatabases
ChronicObstructivePulmonaryDiseasePopulation
PrevalenceofMaleSmokers
PrevalenceofFemaleSmokers
Population65andOver
PrevalenceofAsthma
This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.